BEYOND ELON MUSK l Meet the companies that want to deploy brain chips in people around the world
BEYOND ELON MUSK l Meet the companies that want to deploy brain chips in people around the world
"Did you know that Elon Musk is not alone in this journey of brain chips?
Several other companies are also diving into this intriguing universe. Discover in this video the latest news and amazing advances that are shaping the future integration between mind and technology. Stay tuned, because what you’re about to discover goes beyond Musk’s expectations and promises to revolutionize the neurotechnology landscape.
Prepare for a fascinating revelation and sign up to not miss any detail!"
Not only Elon Musk, but several other companies also show interest in implementing brain chips.
Several devices are being developed for a variety of purposes.
Gradually, the insertion of chips in human brains seems to be approaching the realization. In September, for example, Elon Musk and his brain implant organization,
Neuralink revealed plans to start selecting human volunteers for clinical trials involving their device.
Musk expresses his intention to integrate artificial intelligence (AI) into humans, although Neuralink’s initial focus is to allow paralyzed individuals to control cursors and keyboards through your thoughts.
Adversaries
Neuralink, however, is not alone. A rival company, Synchron, has been able to demonstrate the long-term safety of its implant in its patients;
Other emerging companies, in addition, are also experimenting with similar devices on volunteer participants; meanwhile, new sponsors are emerging.
Certainly, it may seem like a year of significant change, but in reality it is the result of decades of academic work. I believe we’re just beginning to realize the impacts of this exponential growth.
Sumner Norman, co-founder and CEO of Forest Neurotech
BCI chips
Designated as brain-computer interface chips, these devices emerged in the 1960s and 1970s when they began to be experimented on animals,
as reported by Wired magazine.
As researchers improved their understanding of the human brain, these systems became more advanced, allowing paralyzed individuals to move robotic limbs, participate in video games and even communicate exclusively through their thoughts (do you remember Stephen Hawking?).
Originally an area of academic interest, since 2016, BCIs have become the target of a growing number of companies that emerged in this period,
marked by the founding of Neuralink by Musk.
Science and technology have reached a stage of maturity where we can begin to observe tangible and impactful effects on the human condition.
Personalities like Elon Musk recognize these crucial points and invest resources in their commercialization.
Jacob Robinson, founder and CEO of startup Motif Neurotech and professor of engineering at Rice University
Controversy and investments
Despite the controversy surrounding the way it handled monkeys in its preclinical trials, Neuralink recently raised more
$43 million in venture capital investments, bringing the total amount raised to more than $323 million, according to the SEC.
A significant part of this funding originated from the United States government, especially the Defense Advanced Research Projects Agency and Brain Initiative of the National Institutes of Health.
The Initiative has allocated more than $3 billion to the field of neuroscience since it started funding projects in 2014.
More comfortable devices for patients
In an attempt to market systems that provide greater comfort to patients for use in their homes, companies in the sector have sought to create wireless devices with more compact, flexible implants or capable of collecting neural data in a more comprehensive way than
that a set recently presented by the University of Utah, in a comb-like format, plays a central role in research on BCIs.
New York-based Synchron is embedded in this context. Founded in 2016, it develops stent-like brain implants. Over the seven years of its existence,
managed to raise $145 million.
In 2023, other companies also directed their efforts to experiments on humans with new devices.
Precision Neuroscience, for example, based in New York, implanted its chip in three people for 15 minutes.
These people were undergoing brain surgery for different reasons, two of which were conscious during the procedure.
Precision took advantage of the situation because they wanted to verify that their implant was able to read, record and map the electrical activity of the surface of their brains.
Since then, it has conducted similar tests on two more people and plans to expand its studies to other areas in 2024.
The startup was established in 2021, and one of its founders is Benjamin Rapoport, who was also co-founder of Neuralink.
As for the device, they developed a thin film matrix one-fifth the width of a hair that adheres to the surface of the brain.
BEYOND ELON MUSK l Meet the companies that want to deploy brain chips in people around the world
“Did you know that Elon Musk is not alone in this journey of brain chips?
Several other companies are also diving into this intriguing universe. Discover in this video the latest news and amazing advances that are shaping the future integration between mind and technology. Stay tuned, because what you’re about to discover goes beyond Musk’s expectations and promises to revolutionize the neurotechnology landscape.
Prepare for a fascinating revelation and sign up to not miss any detail!”
Not only Elon Musk, but several other companies also show interest in implementing brain chips.
Several devices are being developed for a variety of purposes.
Gradually, the insertion of chips in human brains seems to be approaching the realization. In September, for example, Elon Musk and his brain implant organization,
Neuralink revealed plans to start selecting human volunteers for clinical trials involving their device.
Musk expresses his intention to integrate artificial intelligence (AI) into humans, although Neuralink’s initial focus is to allow paralyzed individuals to control cursors and keyboards through your thoughts.
Adversaries
Neuralink, however, is not alone. A rival company, Synchron, has been able to demonstrate the long-term safety of its implant in its patients;
Other emerging companies, in addition, are also experimenting with similar devices on volunteer participants; meanwhile, new sponsors are emerging.
Certainly, it may seem like a year of significant change, but in reality it is the result of decades of academic work. I believe we’re just beginning to realize the impacts of this exponential growth.
Sumner Norman, co-founder and CEO of Forest Neurotech
BCI chips
Designated as brain-computer interface chips, these devices emerged in the 1960s and 1970s when they began to be experimented on animals,
as reported by Wired magazine.
As researchers improved their understanding of the human brain, these systems became more advanced, allowing paralyzed individuals to move robotic limbs, participate in video games and even communicate exclusively through their thoughts (do you remember Stephen Hawking?).
Originally an area of academic interest, since 2016, BCIs have become the target of a growing number of companies that emerged in this period,
marked by the founding of Neuralink by Musk.
Science and technology have reached a stage of maturity where we can begin to observe tangible and impactful effects on the human condition.
Personalities like Elon Musk recognize these crucial points and invest resources in their commercialization.
Jacob Robinson, founder and CEO of startup Motif Neurotech and professor of engineering at Rice University
Controversy and investments
Despite the controversy surrounding the way it handled monkeys in its preclinical trials, Neuralink recently raised more
$43 million in venture capital investments, bringing the total amount raised to more than $323 million, according to the SEC.
A significant part of this funding originated from the United States government, especially the Defense Advanced Research Projects Agency and Brain Initiative of the National Institutes of Health.
The Initiative has allocated more than $3 billion to the field of neuroscience since it started funding projects in 2014.
More comfortable devices for patients
In an attempt to market systems that provide greater comfort to patients for use in their homes, companies in the sector have sought to create wireless devices with more compact, flexible implants or capable of collecting neural data in a more comprehensive way than
that a set recently presented by the University of Utah, in a comb-like format, plays a central role in research on BCIs.
New York-based Synchron is embedded in this context. Founded in 2016, it develops stent-like brain implants. Over the seven years of its existence,
managed to raise $145 million.
In 2023, other companies also directed their efforts to experiments on humans with new devices.
Precision Neuroscience, for example, based in New York, implanted its chip in three people for 15 minutes.
These people were undergoing brain surgery for different reasons, two of which were conscious during the procedure.
Precision took advantage of the situation because they wanted to verify that their implant was able to read, record and map the electrical activity of the surface of their brains.
Since then, it has conducted similar tests on two more people and plans to expand its studies to other areas in 2024.
The startup was established in 2021, and one of its founders is Benjamin Rapoport, who was also co-founder of Neuralink.
As for the device, they developed a thin film matrix one-fifth the width of a hair that adheres to the surface of the brain.
